Drx Choice Fiber Therapy Powder, For Solution
NDC Package 68163-517-16

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Drx Choice Fiber Therapy (methylcellulose) powders is •MIX THIS PRODUCT (CHILD OR ADULT DOSE) WITH AT LEAST 8 OUNCES (A FULL GLASS) OF WATER OR OTHER FLUID. This formulation utilizes a powder, for solution delivery system. Marketed by Raritan Pharmaceuticals Inc, this product is identified by NDC 68163-517 and is authorized under FDA application M007.

Identification & Billing

NDC Package Code
68163-517-16
Package Description
479 g in 1 BOTTLE, PLASTIC
Product Code
68163-517
11-Digit Billing Format
68163051716
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Drx Choice Fiber Therapy
Non-Proprietary Name
Methylcellulose
Substance Name
Methylcellulose (4000 Mpa.s)
Dosage Form
Powder, For Solution - An intimate mixture of dry, finely divided drugs and/or chemicals, which, upon the addition of suitable vehicles, yields a solution.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
METHYLCELLULOSE (4000 MPA.S) 2 g/10.2g
Usage Information
•MIX THIS PRODUCT (CHILD OR ADULT DOSE) WITH AT LEAST 8 OUNCES (A FULL GLASS) OF WATER OR OTHER FLUID. TAKING THIS PRODUCT WITHOUT ENOUGH LIQUID MAY CAUSE CHOKING. SEE CHOKING WARNING•use product at the first sign of constipation or irregularity•put one dose in a full glass of cold water•stir briskly and drink promptly•drinking another glass of water is helpfulAgeDoseadults & children 12 years of age and overstart with 1 rounded tablespoon. Increase as needed, 1 rounded tablespoon at a time, up to 3 times per day.children 6 - 11 years of agestart with 2 level teaspoons. Increase as needed, 2 level teaspoons at a time, up to 3 times per day.children under 6 years of ageconsult a physician

Regulatory & Marketing

Labeler Name
Raritan Pharmaceuticals Inc
Product Type
Human Otc Drug
FDA Application #
M007
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
07-18-2022
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 68163-517-16 identifies a specific commercial package of 479 g in 1 bottle, plastic of Drx Choice Fiber Therapy, a human over the counter drug labeled by Raritan Pharmaceuticals Inc. This powder, for solution is formulated for oral use and contains methylcellulose (4000 mpa.s) as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Raritan Pharmaceuticals Inc on July 18, 2022. The current certification is valid through December 31, 2026.

How is this Raritan Pharmaceuticals Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 68163051716. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
68163-517-16
11-Digit CMS (5-4-2)
68163-0517-16

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.